What they were paid
Aquestive Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $127,500 | $0 | $143,220 | $3,921 | $274,641 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Aquestive Therapeutics, Inc. DEF 14A filed April 24, 2026, accession 0001140361-26-016757, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Aquestive Therapeutics pays directors a $50,000 cash retainer and $143,220 in Stock Options.
Committees
FY2025 · as the proxy prints themAudit · Compensation · Nominating/Governance
The rest of the Aquestive Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Abigail L. Jenkins | Independent Director | $200,917 |
| Daniel Barber | Director | $0 |
| John S. Cochran | Independent Director | $240,919 |
| Julie Krop, M.D | Independent Director | $233,220 |
| Marco Taglietti, M.D | Independent Director | $213,412 |
| Timothy E. Morris | Independent Director | $237,612 |
The full Aquestive Therapeutics compensation record
free company briefThis page is one director within Aquestive Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat